These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14870835)

  • 21. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
    Rossi JF
    Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
    [No Abstract]   [Full Text] [Related]  

  • 22. Agents under investigation for the treatment and prevention of neutropenia.
    Huston A; Lyman GH
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1831-40. PubMed ID: 17970641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colony-stimulating factors stimulate some treatments, continue to evolve.
    Volkers N
    J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
    [No Abstract]   [Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 25. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tips on the use of granulocyte colony-stimulating factors in cancer patients predisposed to chemotherapy - induced febrile neutropenia].
    Murakawa Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):693-6. PubMed ID: 23863645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Appropriate use of granulocyte-colony stimulating factor].
    Ohashi K; Kiura K
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():336-40. PubMed ID: 25831778
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
    Spaëth D; Geoffrois L; Conroy T
    Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-macrophage colony-stimulating factor in neutropenia.
    Hogan KR; Peters MD
    DICP; 1991 Jan; 25(1):32-5. PubMed ID: 2008785
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy.
    Lifton R; Bennett JM
    Hematol Oncol Clin North Am; 1996 Aug; 10(4):825-39. PubMed ID: 8811304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 34. Misleading title and abstract in recent granulocyte-macrophage colony-stimulating factor trial.
    Grossman JS; Kroener J
    J Clin Oncol; 1999 May; 17(5):1644-5. PubMed ID: 10334557
    [No Abstract]   [Full Text] [Related]  

  • 35. ESMO recommendations for the application of haematopoietic growth factors (hGFs).
    Ann Oncol; 2001 Sep; 12(9):1219-20. PubMed ID: 11697831
    [No Abstract]   [Full Text] [Related]  

  • 36. Colony stimulating factors for chemotherapy induced febrile neutropenia.
    Clark OA; Lyman G; Castro AA; Clark LG; Djulbegovic B
    Cochrane Database Syst Rev; 2003; (3):CD003039. PubMed ID: 12917942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid growth factors clinical practice guidelines in oncology.
    Crawford J; Althaus B; Armitage J; Blayney DW; Cataland S; Dale DC; Demetri GD; Foran J; Heaney ML; Htoy S; Kloth DD; Lyman GH; Michaud L; Motl S; Vadhan-Raj S; Wong MK;
    J Natl Compr Canc Netw; 2005 Jul; 3(4):540-55. PubMed ID: 16038645
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myelosuppression due to antineoplastic agents].
    Shigeoka Y; Shimizu E
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
    Mori PG; Pasino M; Dufour C; Boeri E; Molinari AC
    Blood; 1994 Nov; 84(9):3244-5. PubMed ID: 7524771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.